One of the most salient topics in the United States right now in pharma is market access and drug affordability, and one thing that’s driving that topic in this moment are the drug pricing
Sometimes the conversation about drug pricing within the pharma industry and the one going on in the wider world seem like they're in completely different languages.
Just days after the US presidential race officially narrowed to a contest between President Joe Biden and former president Donald Trump, it’s no surprise that Biden’s State of the Union spe
On the heels of a setback in pharma’s legal attempts to block Medicare’s new medicine price negotiation powers, the US government has said all drugmakers whose products ar
The passage of the Inflation Reduction Act (IRA) signifies more than just a legislative milestone; it acts as a clarion call to the pharmaceutical industry.